BIOTRICITY INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q1+Q2+Q3+Q4) vs FY2024 (Q1+Q2+Q3+Q4)
Revenue
$15M
↑+16.5% +$2Mvs FY2024 (Q1+Q2+Q3+Q4)
Gross Profit
$13M
↑+27.1% +$3Mvs FY2024 (Q1+Q2+Q3+Q4)
Operating profit
$997K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q1+Q2+Q3+Q4) | FY2024 (Q1+Q2+Q3+Q4) |
|---|---|---|
| Revenue | $15M | $13M |
| COGS | $3M | $3M |
| Gross Profit | $13M | $10M |
| R&D | $2M | $2M |
| SG&A | $9M | $12M |
| D&A | $0 | $6K |
| Other OpEx | $0 | $0 |
| Operating Income | $997K | $0 |
| Interest Exp. | $997K | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · BTCY · Comparing FY2025 (Q1+Q2+Q3+Q4) vs FY2024 (Q1+Q2+Q3+Q4)